Synthesis of Carboxy-Dimethylmaleic Amide Linked Polymer Conjugate Based Ultra-pH-sensitive Nanoparticles for Enhanced Antitumor Immunotherapy.

Synthesis of Carboxy-Dimethylmaleic Amide Linked Polymer Conjugate Based Ultra-pH-sensitive Nanoparticles for Enhanced Antitumor Immunotherapy.
复制标题

DOI:
10.1021/acsmacrolett.0c00755
复制
发表时间:
2020-11-17
期刊:
影响因子:
7.015
通讯作者:
Huang X
Huang X
中科院分区:
化学1区
文献类型:
--
作者:
Lang S;Tan Z;Wu X;Huang X

文献摘要

参考文献

相似文献

细胞毒性T淋巴细胞(CTL)是抗癌免疫治疗的重要工具。为了激发强大的CTL活性,已经合成了基于甲氧基聚(乙二醇)-B-[聚(二异丙基氨基)乙基甲基丙烯酸酯]的超pH敏感纳米颗粒(NP)作为疫苗递送平台。将代表性CTL表位卵清蛋白(OVA)肽抗原通过酸响应性羧基-二甲基马来酰胺接头(CDM)共价缀合至聚合物主链,产生聚合物P-CDM-OVA。有趣的是,虽然P-CDM-OVA在pH 6.4缓冲液中缓慢释放OVA肽,但加入模拟细胞和/或体内环境中遇到的蛋白质的牛血清白蛋白(BSA)显著加速了释放过程。当基于P-CDM-OVA的超pH敏感颗粒与抗原呈递细胞一起孵育时,观察到OVA的成功细胞表面呈递。与游离肽或先前报道的封装OVA的缩醛化葡聚糖颗粒相比,这些P-CDM-OVA NP大大增强了体内CTL应答。还研究了P-CDM的佐剂缀合,并且P-CDM-OVA和P-CDM-佐剂缀合物NP的共施用进一步改善了体内CTL应答并有效地减少了小鼠中的肿瘤生长。因此,CDM连接的聚合物为抗癌免疫治疗提供了一个有前途的平台。
Cytotoxic T lymphocytes (CTLs) are an important tool for anticancer immunotherapy. To elicit powerful CTL activities, ultra-pH-sensitive nanoparticles (NPs) based on methoxy poly(ethylene glycol)-b-[poly(diisopropylamino)ethyl methacrylate] have been synthesized as a vaccine delivery platform. A representative CTL epitope, ovalbumin (OVA) peptide antigen, was covalently conjugated to the polymer backbone through an acid responsive carboxy-dimethylmaleic amide linker (CDM) resulting in polymer P-CDM-OVA. Interestingly, while the P-CDM-OVA released OVA peptide slowly in a pH 6.4 buffer, the addition of bovine serum albumin (BSA) mimicking proteins encountered in a cellular and/or in vivo environment significantly accelerated the release process. Successful cell surface presentation of OVA was observed when P-CDM-OVA based ultra-pH-sensitive particles were incubated with antigen presenting cells. These P-CDM-OVA NPs greatly enhanced CTL responses in vivo compared to the free peptide or the previously reported acetalated dextran particles encapsulating OVA. The P-CDM was also investigated for adjuvant conjugation, and the coadministration of P-CDM-OVA and the P-CDM-adjuvant conjugate NPs further improved CTL responses in vivo and effectively reduced tumor growth in mice. Thus, the CDM linked polymer presents a promising platform for anticancer immunotherapy.
DOI: 10.1038/nnano.2017.52
发表时间: 2017-07
影响因子: 38.3
作者:
Luo M;Wang H;Wang Z;Cai H;Lu Z;Li Y;Du M;Huang G;Wang C;Chen X;Porembka MR;Lea J;Frankel AE;Fu YX;Chen ZJ;Gao J
通讯作者: Gao J
DOI: 10.1021/ja5053158
发表时间: 2014-08-06
影响因子: 15
作者:
Ma, Xinpeng;Wang, Yiguang;Zhao, Tian;Li, Yang;Su, Lee-Chun;Wang, Zhaohui;Huang, Gang;Sumer, Baran D.;Gao, Jinming
通讯作者: Gao, Jinming
DOI: 10.1016/j.vaccine.2014.02.027
发表时间: 2014-05-19
期刊: VACCINE
影响因子: 5.5
作者:
Ilyinskii, Petr O.;Roy, Christopher J.;O'Neil, Conlin P.;Browning, Erica A.;Pittet, Lynnelle A.;Altreuter, David H.;Alexis, Frank;Tonti, Elena;Shi, Jinjun;Basto, Pamela A.;Iannacone, Matteo;Radovic-Moreno, Aleksandar F.;Langer, Robert S.;Farokhzad, Omid C.;von Andrian, Ulrich H.;Johnston, Lloyd P. M.;Kishimoto, Takashi Kei
通讯作者: Kishimoto, Takashi Kei
DOI: 10.1172/jci79915
发表时间: 2015-06-01
影响因子: 15.9
作者:
Hanson, Melissa C.;Crespo, Monica R.;Irvine, Darrell J.
通讯作者: Irvine, Darrell J.
DOI: 10.1016/j.jconrel.2017.02.031
发表时间: 2017-04-10
影响因子: 10.8
作者:
Mohsen, Mona O.;Gomes, Ariane C.;Bachmann, Martin F.
通讯作者: Bachmann, Martin F.